A. Arnold

M. N. Levine1
M. Gent1
H. Abu-Zahra1
B. Findlay1
J. Skillings1
1M. N. Levine
1M. Gent
1H. Abu-Zahra
Learn More
A randomised trial has previously been repeated in which 437 women with node positive breast cancer received either a 12-week chemohormonal regimen consisting of cyclophosphamide, methotrexate, fluorouracil, vincristine, prednisone, adriamycin and tamoxifen or 36 weeks of CMFVP. The present analysis concerns the local recurrence rates for the 122 lumpectomy(More)
  • 1